Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Today, members of the Obesity Care Continuum (OCC) applauded the Food and Drug Administration's (FDA) approval of a new obesity drug – Belviq...
Members of the Obesity Care Continuum (OCC) are pleased with the FDA's Advisory Committee near unanimous vote to approve QNEXA, a new drug to treat...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.